Abstract
Amiodarone is a powerful antiarrhythmic drug; however, its use may be complicated by thyrotoxicosis. When this occurs, clinicians must balance the continuation of amiodarone for antiarrhythmic purposes, and the discontinuation of treatment in order to prevent aggravation of the thyrotoxicosis. We studied the consequences of continuation or cessation of amiodarone in patients with type II amiodarone-induced thyrotoxicosis. Consecutive patients who developed type II amiodarone-induced thyrotoxicosis between September 1997 and September 2000 were studied. Amiodarone was continued in patients with previous ventricular arrhythmia or supraventricular arrhythmia associated with severe haemodynamic changes and was withdrawn in the other patients. In patients with persistent, severe symptomatic thyrotoxicosis, corticosteroids were added to therapy. Thirteen patients were studied (nine with previous atrial fibrillation/flutter and four with ventricular tachycardia). Amiodarone treatment was continued in ten patients, including eight patients who received corticosteroids, and was temporarily halted in three patients. All patients recovered, with no difference in the duration of thyrotoxicosis between the two groups. Corticosteroid treatme...Continue Reading
References
Oct 1, 1975·The Journal of Clinical Endocrinology and Metabolism·J C SavoieF Leger
Jul 25, 1992·BMJ : British Medical Journal·P H DaviesM C Sheppard
Dec 1, 1984·European Journal of Clinical Investigation·A F LegerJ C Savoie
Jan 7, 1998·The American Journal of Cardiology·K SakataK Ishikawa
Dec 19, 1998·Journal of the American College of Cardiology·S C CrednerS H Hohnloser
Sep 14, 1999·Journal of the American College of Cardiology·M A WoodL S Liebovitch
Apr 6, 2000·Pacing and Clinical Electrophysiology : PACE·T ChalvidanP Djiane
Feb 15, 2001·The New England Journal of Medicine·I Klein, K Ojamaa
Mar 7, 2001·The Journal of Clinical Endocrinology and Metabolism·G H Daniels
Feb 13, 2002·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Athanasios G ManolisCostas G Tsatiris
Feb 19, 2002·Clinical Endocrinology·S E M EatonW M Bennet
May 16, 2002·Heart·G NicholG Wells
Nov 13, 2002·Journal of the American College of Cardiology·Gabriel GregoratosStephen L Winters
Sep 3, 2003·Journal of Cardiovascular Electrophysiology·Paul Dorian, Iqwal Mangat
Aug 17, 2004·Journal of Cardiac Failure·Raymond L BenzaUNKNOWN OPTIME-CHF Investigators
Oct 12, 2004·Clinical Endocrinology·Luigi BartalenaEnio Martino
Dec 8, 2004·Journal of the American College of Cardiology·Kumaraswamy NanthakumarDouglas S Lee
Jun 2, 2005·JAMA : the Journal of the American Medical Association·Oussama M WazniAndrea Natale
Citations
Feb 20, 2014·HNO·C MeerweinG F Huber
Mar 13, 2014·Heart, Lung & Circulation·Nadia PatelGerald Kaye
Nov 28, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Silvia A Eskes, Wilmar M Wiersinga
Sep 21, 2006·Clinical Endocrinology·Leandro Arthur DiehlWilmar M Wiersinga
May 4, 2011·Clinical Endocrinology·Sheba AhmedThera P Links
Jun 19, 2007·Journal of the American College of Cardiology·David ConenStefan Osswald
Aug 16, 2016·Thyroid : Official Journal of the American Thyroid Association·Douglas S RossMartin A Walter
Nov 26, 2009·Nature Reviews. Endocrinology·Janna Cohen-LehmanIrwin Klein
Sep 10, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Marius N StanRebecca S Bahn
Jan 10, 2019·Health Science Reports·Jennifer M YamamotoFrancisco J Cordova
Dec 18, 2020·Frontiers in Cardiovascular Medicine·Marvin Wei Jie Chua, Shao Feng Mok
Sep 22, 2018·Annales d'endocrinologie·Salwan MaqdasyIgor Tauveron
May 16, 2020·Annales d'endocrinologie·Louis SchubertLionel Groussin